Pharma Marketing Network

"Follow the money," was the advice Deep Throat gave to Bob Woodward during the Watergate investigation. The same advice will help us understand which...

Click on the image to enlarge for easier reading:BackStoryYes, PhRMA is now on YouTube! Actually, it has launched an integrated media campaign called "Sharing...

Researchers at Wake Forest University Baptist Medical Center found that "physicians are over three times more likely to prescribe generic medications to uninsured patients...

In 2006, the pharmaceutical industry provided $1.19 billion to sponsor physician continuing medical education (CME) programs in the US ($1.44 billion if you include...

So far, Barack Obama is the choice by far of the US pharmaceutical company respondents to my Obama vs. McCain Survey -- 46% of...

The Wall Street Journal reports that Pfizer will air new Lipitor TV ads that feature a non-celebrity:"The new television ad, set to debut Tuesday,...

This article, written by a marketer with firsthand experience, provides an overview of the pharmaceutical markets and promotional practices in India.

There is no doubt that the face of pharmaceutical sales is going to change in the next five years. With more than one rep per physician, the industry has seen a 25% drop in call productivity over the past 5 years, down a whopping 23% in 2004 alone. The industry will have to adapt its sales model to meet the new challenges ahead. This article offers insights on the new sales model and how to achieve it from pharma experts who presented at a recent eyeforpharma Sales Force Effectiveness Summit.

This article is the second in a series of articles focused on improving pharmaceutical sales call effectiveness. It is based on an interview and webinar featuring Ian McKinnon, Senior Vice President, TNS Healthcare, who spoke on building and developing 'power messages,' which are messages that drive sales results.

To better understand the impact of this code on the pharmaceutical industry, Pharma Marketing News surveyed readers between July 10, 2008 and August 7, 2008, and collected comments from pharma-focused blogs and bulletin boards. This article is a summary of the PMN survey results and opinions of experts, bloggers, and anonymous commentators.